242 related articles for article (PubMed ID: 25133395)
21. The socioeconomic costs of mental illness in Spain.
Oliva-Moreno J; López-Bastida J; Montejo-González AL; Osuna-Guerrero R; Duque-González B
Eur J Health Econ; 2009 Oct; 10(4):361-9. PubMed ID: 19031056
[TBL] [Abstract][Full Text] [Related]
22. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
Reimer J; Vogelmann T; Trümper D; Scherbaum N
Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and costs of depressive disorder in Spain: the EPICO study.
Vieta E; Alonso J; Pérez-Sola V; Roca M; Hernando T; Sicras-Mainar A; Sicras-Navarro A; Herrera B; Gabilondo A
Eur Neuropsychopharmacol; 2021 Sep; 50():93-103. PubMed ID: 34058711
[TBL] [Abstract][Full Text] [Related]
24. The burden of COPD in Spain: results from the Confronting COPD survey.
Izquierdo JL
Respir Med; 2003 Mar; 97 Suppl C():S61-9. PubMed ID: 12647944
[TBL] [Abstract][Full Text] [Related]
25. Initial assessment of the economic burden of major parasitic helminth infections to the ruminant livestock industry in Europe.
Charlier J; Rinaldi L; Musella V; Ploeger HW; Chartier C; Vineer HR; Hinney B; von Samson-Himmelstjerna G; Băcescu B; Mickiewicz M; Mateus TL; Martinez-Valladares M; Quealy S; Azaizeh H; Sekovska B; Akkari H; Petkevicius S; Hektoen L; Höglund J; Morgan ER; Bartley DJ; Claerebout E
Prev Vet Med; 2020 Sep; 182():105103. PubMed ID: 32750638
[TBL] [Abstract][Full Text] [Related]
26. Cost-of-illness of melanoma in Europe - a modelling approach.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
[TBL] [Abstract][Full Text] [Related]
27. The burden of migraine in Spain: beyond direct costs.
Badia X; Magaz S; Gutiérrez L; Galván J
Pharmacoeconomics; 2004; 22(9):591-603. PubMed ID: 15209528
[TBL] [Abstract][Full Text] [Related]
28. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.
Fattore G; Torbica A; Susi A; Giovanni A; Benelli G; Gozzo M; Toso V
BMC Neurol; 2012 Nov; 12():137. PubMed ID: 23150894
[TBL] [Abstract][Full Text] [Related]
29. [Cost of illness and health service patterns in Morbus Parkinson in Austria].
von Campenhausen S; Winter Y; Gasser J; Seppi K; Reese JP; Pfeiffer KP; Geiger-Gritsch S; Bötzel K; Siebert U; Oertel WH; Dodel R; Poewe W
Wien Klin Wochenschr; 2009; 121(17-18):574-82. PubMed ID: 19890747
[TBL] [Abstract][Full Text] [Related]
30. Direct health care costs of diabetic patients in Spain.
Oliva J; Lobo F; Molina B; Monereo S
Diabetes Care; 2004 Nov; 27(11):2616-21. PubMed ID: 15504995
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional study.
Vandepitte S; Van Wilder L; Putman K; Van Den Noortgate N; Verhaeghe S; Trybou J; Annemans L
BMC Geriatr; 2020 Jan; 20(1):18. PubMed ID: 31948386
[TBL] [Abstract][Full Text] [Related]
32. Cost of disorders of the brain in Denmark.
Olesen J; Sobscki P; Truelsen T; Sestoft D; Jönsson B
Nord J Psychiatry; 2008; 62(2):114-20. PubMed ID: 18569774
[TBL] [Abstract][Full Text] [Related]
33. Cost of illness and its predictors for Parkinson's disease in Germany.
Spottke AE; Reuter M; Machat O; Bornschein B; von Campenhausen S; Berger K; Koehne-Volland R; Rieke J; Simonow A; Brandstaedter D; Siebert U; Oertel WH; Ulm G; Dodel R
Pharmacoeconomics; 2005; 23(8):817-36. PubMed ID: 16097843
[TBL] [Abstract][Full Text] [Related]
34. Economic impact of patients admitted to stroke units in Spain.
Alvarez-Sabín J; Quintana M; Masjuan J; Oliva-Moreno J; Mar J; Gonzalez-Rojas N; Becerra V; Torres C; Yebenes M;
Eur J Health Econ; 2017 May; 18(4):449-458. PubMed ID: 27084749
[TBL] [Abstract][Full Text] [Related]
35. Costs of illness in a Russian cohort of patients with Parkinson's disease.
Winter Y; von Campenhausen S; Popov G; Reese JP; Klotsche J; Bötzel K; Gusev E; Oertel WH; Dodel R; Guekht A
Pharmacoeconomics; 2009; 27(7):571-84. PubMed ID: 19663528
[TBL] [Abstract][Full Text] [Related]
36. The cost of mental health: Where do we stand in France?
Laidi C; Blampain-Segar L; Godin O; de Danne A; Leboyer M; Durand-Zaleski I
Eur Neuropsychopharmacol; 2023 Apr; 69():87-95. PubMed ID: 36958109
[TBL] [Abstract][Full Text] [Related]
37. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
Chuvarayan Y; Finger RP; Köberlein-Neu J
Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
[TBL] [Abstract][Full Text] [Related]
38. The current total economic burden of diabetes mellitus in the Netherlands.
Peters ML; Huisman EL; Schoonen M; Wolffenbuttel BHR
Neth J Med; 2017 Sep; 75(7):281-297. PubMed ID: 28956787
[TBL] [Abstract][Full Text] [Related]
39. The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review.
Floyd DN; Langham S; Séverac HC; Levesque BG
Dig Dis Sci; 2015 Feb; 60(2):299-312. PubMed ID: 25258034
[TBL] [Abstract][Full Text] [Related]
40. [Costs of Depression in Germany - Systematic Review].
Eden JL; Konnopka A; König HH
Psychiatr Prax; 2021 Sep; 48(6):290-300. PubMed ID: 33773504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
